Company Filing History:
Years Active: 2025
Title: Innovations by Anna Piskorz in Cancer Research
Introduction
Anna Piskorz is a notable inventor based in London, GB, recognized for her contributions to cancer research through innovative methodologies. With a total of 2 patents, she has made significant strides in the field of molecular diagnostics and treatment response prediction.
Latest Patents
Her latest patents include "Enhanced detection of target DNA by fragment size analysis," which provides a computer-implemented method for detecting variant nucleic acid from a cell-free nucleic acid-containing sample. This method involves processing data representing fragment sizes of nucleic acid fragments to classify samples based on the presence of variant nucleic acids. Another significant patent is focused on "Methods for predicting treatment response in cancers." This invention utilizes a tumor copy number profile to predict a cancer patient's response to treatment, particularly assessing the likelihood of resistance to agents that induce micronuclei formation.
Career Highlights
Anna Piskorz is currently associated with Cancer Research Technology Limited, where she applies her expertise to advance cancer research. Her work is pivotal in developing methods that enhance the understanding of cancer genomics and treatment efficacy.
Collaborations
She collaborates with esteemed colleagues such as James Brenton and Geoff Macintyre, contributing to a dynamic research environment that fosters innovation in cancer treatment strategies.
Conclusion
Anna Piskorz's innovative patents and collaborative efforts significantly impact cancer research, paving the way for improved diagnostic and treatment methodologies. Her work exemplifies the vital role of inventors in advancing medical science.